ArticleRespiratory medicine and research2023

Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic.

Marie Veron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.